Publications

Found 1 results
Filters: Author is A.L. Guo  [Clear All Filters]
2011
W. W. Zhu, Ma, X. L., Guo, A. L., Zhao, H. Y., and Luo, H. H., Neuroprotective effects of NEP1-40 and fasudil on Nogo-A expression in neonatal rats with hypoxic-ischemic brain damage, vol. 10, pp. 2987-2995, 2011.
Bertrand J, Winton MJ, Rodriguez-Hernandez N, Campenot RB, et al. (2005). Application of rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats. J. Neurosci. 25: 1113-1121. http://dx.doi.org/10.1523/JNEUROSCI.3931-04.2005 PMid:15689547 Cao Y, Shumsky JS, Sabol MA, Kushner RA, et al. (2008). Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil. Neural Repair 22: 262-278. http://dx.doi.org/10.1177/1545968307308550 PMid:18056009    PMCid:2853251 Fournier AE, Takizawa BT and Strittmatter SM (2003). Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23: 1416-1423. PMid:12598630 Gillani RL, Tsai SY, Wallace DG, O’Brien TE, et al. (2010). Cognitive recovery in the aged rat after stroke and anti- Nogo-A immunotherapy. Behav. Brain Res. 208: 415-424. http://dx.doi.org/10.1016/j.bbr.2009.12.015 PMid:20035795    PMCid:2831114 Goldshmit Y, Galea MP, Wise G, Bartlett PF, et al. (2004). Axonal regeneration and lack of astrocytic gliosis in EphA4- deficient mice. J. Neurosci. 24: 10064-10073. http://dx.doi.org/10.1523/JNEUROSCI.2981-04.2004 PMid:15537875 GrandPre T, Li S and Strittmatter SM (2002). Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417: 547-551. http://dx.doi.org/10.1038/417547a PMid:12037567 Guo AL, Zhu WW, Wang L and Pan F (2008). Effect of NEP1-40 in inhibiting neurite outgrowth on neonatal rats with hypoxic ischemic brain damage. Chin. J. Child Health Care 16: 679-668. Hossain MA (2008). Hypoxic-ischemic injury in neonatal brain: involvement of a novel neuronal molecule in neuronal cell death and potential target for neuroprotection. Int. J. Dev. Neurosci. 26: 93-101. http://dx.doi.org/10.1016/j.ijdevneu.2007.08.013 PMid:17936538    PMCid:2350216 Kim SS, Lee KH, Sung DK, Shim JW, et al. (2008). Erythropoietin attenuates brain injury, subventricular zone expansion, and sensorimotor deficits in hypoxic-ischemic neonatal rats. J. Korean Med. Sci. 23: 484-491. http://dx.doi.org/10.3346/jkms.2008.23.3.484 PMid:18583887    PMCid:2526527 Kottis V, Thibault P, Mikol D, Xiao ZC, et al. (2002). Oligodendrocyte-myelin glycoprotein (OMgp) is an inhibitor of neurite outgrowth. J. Neurochem. 82: 1566-1569. http://dx.doi.org/10.1046/j.1471-4159.2002.01146.x PMid:12354307 Kubo T and Yamashita T (2007). Rho-ROCK inhibitors for the treatment of CNS injury. Recent Patents CNS Drug Discov. 2: 173-179. http://dx.doi.org/10.2174/157488907782411738 PMid:18221230 McKerracher L, David S, Jackson DL, Kottis V, et al. (1994). Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron 13: 805-811. http://dx.doi.org/10.1016/0896-6273(94)90247-X Mukhopadhyay G, Doherty P, Walsh FS, Crocker PR, et al. (1994). A novel role for myelin-associated glycoprotein as an inhibitor of axonal regeneration. Neuron 13: 757-767. http://dx.doi.org/10.1016/0896-6273(94)90042-6 Oertle T, van der Haar ME, Bandtlow CE, Robeva A, et al. (2003). Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J. Neurosci. 23: 5393-5406. PMid:12843238 Perlman JM (2006). Intervention strategies for neonatal hypoxic-ischemic cerebral injury. Clin. Ther. 28: 1353-1365. http://dx.doi.org/10.1016/j.clinthera.2006.09.005 PMid:17062309 Prinjha R, Moore SE, Vinson M, Blake S, et al. (2000). Inhibitor of neurite outgrowth in humans. Nature 403: 383-384. http://dx.doi.org/10.1038/35000287 PMid:10667780 Rice JE III, Vannucci RC and Brierley JB (1981). The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9: 131-141. http://dx.doi.org/10.1002/ana.410090206 PMid:7235629 Savio T and Schwab ME (1990). Lesioned corticospinal tract axons regenerate in myelin-free rat spinal cord. Proc. Natl. Acad. Sci. U. S. A. 87: 4130-4133. http://dx.doi.org/10.1073/pnas.87.11.4130 Schnaar RL and Lopez PH (2009). Myelin-associated glycoprotein and its axonal receptors. J. Neurosci. Res. 87: 3267- 3276. http://dx.doi.org/10.1002/jnr.21992 PMid:19156870    PMCid:2892843 Vicari RM, Chaitman B, Keefe D, Smith WB, et al. (2005). Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J. Am. Coll. Cardiol. 46: 1803-1811. http://dx.doi.org/10.1016/j.jacc.2005.07.047 PMid:16286163 Walmsley AR and Mir AK (2007). Targeting the Nogo-A signalling pathway to promote recovery following acute CNS injury. Curr. Pharm. Des. 13: 2470-2484. http://dx.doi.org/10.2174/138161207781368611 PMid:17692015 Wang H, Yao Y, Jiang X, Chen D, et al. (2006). Expression of Nogo-A and NgR in the developing rat brain after hypoxia-ischemia. Brain Res. 1114: 212-220. http://dx.doi.org/10.1016/j.brainres.2006.07.056 Wong ST, Henley JR, Kanning KC, Huang KH, et al. (2002). A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat. Neurosci. 5: 1302-1308. http://dx.doi.org/10.1038/nn975 PMid:12426574 Yesilirmak DC, Kumral A, Tugyan K, Cilaker S, et al. (2008). Effects of activated protein C on neonatal hypoxic ischemic brain injury. Brain Res. 1210: 56-62. http://dx.doi.org/10.1016/j.brainres.2008.02.088 PMid:18420181